possibly life- threatening adverse drug reaction that typically occurs two to eight weeks following
exposure to anticonvulsants, sulfonamides and antiviral medications, amongst other implicated
drugs. Patients typically present with fever, lymphadenopathy, rash and end-organ
involvement. Key laboratory findings include atypical lymphocytosis, eosinophilia, and elevated
liver enzymes. We report a case of DRESS with a latency period more prolonged than any
previously presented in the medical literature to the best of our knowledge.
Methods: The patient met all criteria for DRESS according to the RegiSCAR criteria which is a
widely used scoring system for the diagnosis of DRESS.
Results: An 8-year old with history of uncontrolled complex seizures with control on
zonisamide presented with diffuse maculopapular rash, lymphadenopathy, mild facial edema
and fever. Her lab values showed white blood cell count– 16.5 k/CMM, eosinophil %-15,
absolute eosinophil count–2,475, atypical lymphocytes-23%, elevated liver function tests:
alanine aminotransferase-338 unit/L, aspartate aminotransferase 144 unit/L, alkaline
phosphatase-582 unit/L, ammonia-102 UMOL/L. HHV-6 IgM was elevated. All other studies
including antistreptolysin antibodies, cytomegalovirus, parvovirus, enterovirus were negative.
Abdominal ultrasound showed mild hepatosplenomegaly. Zonisamide was discontinued. The
child was started on high dose steroids and hydroxyzine. After 5 days of high dose steroids; the
rash had improved and patient was started on a steroid wean.
Conclusions: We believe this is the first reported case of DRESS with a latency period of 84
weeks and 5 days.